603014.SH上海证券交易所 · 主板 Main
Weigao Blood Purification 威高血净
Medical Devices 医疗器械
¥31.05−¥0.10 · −0.32%
Open 开盘
¥31.15
High 最高
¥31.52
Low 最低
¥30.88
Prev Close 昨收
¥31.15
Volume 成交量
77.5万股
Turnover 成交额
¥2,410.7万
Mkt Cap 总市值
¥216亿
P/E 市盈率
43.9×
Recent Activity 近期动态All Filings 全部公告 →
25 significant filings since 31 May 2026: 1 on change of control, 6 on acquisition or disposal and 3 on new listing, and 4 other kinds. The latest, on 25 Sep 2026: 关于股东权益变动暨控股股东变更的提示性公告.
自 31 May 2026 起有 25 份重大公告：change of control 1 份、acquisition or disposal 6 份、new listing 3 份，另有 4 类。最新一份（25 Sep 2026）：关于股东权益变动暨控股股东变更的提示性公告。
Price History 价格走势
250 trading days 个交易日 · High 最高 ¥45.74 · Low 最低 ¥29.7430.0032.5035.0037.5040.0042.5045.00
Volume 成交量
1,757.1万
Sep 25Dec 25Mar 26Jul 26Sep 26
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Medical Devices 医疗器械 · 140 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥216亿 | ¥48亿 | 11th highest of 140 · 140 家中第 11 高 | |
| Trailing P/E 市盈率 | 43.9x | 40.4x | 47th highest of 101 · 101 家中第 47 高 | |
| P/B 市净率 | 1.8x | 2.4x | 43rd lowest of 140 · 140 家中第 43 低 | |
| Revenue Growth 营收增速 | -0.4% | 4.0% | 48th lowest of 140 · 140 家中第 48 低 | |
| Profit Growth 净利增速 | 4.3% | -2.6% | 63rd highest of 140 · 140 家中第 63 高 | |
| Gross Margin 毛利率 | 37.9% | 55.2% | 38th lowest of 140 · 140 家中第 38 低 | |
| Net Margin 净利率 | 13.1% | 10.7% | 58th highest of 140 · 140 家中第 58 高 | |
| Return on Equity 净资产收益率 | 3.2% | 2.4% | 61st highest of 140 · 140 家中第 61 高 | |
| Debt to Assets 资产负债率 | 14.6% | 19.2% | 47th lowest of 140 · 140 家中第 47 低 | |
| Grade Score 评级得分 | 49 | 52 | 66th lowest of 140 · 140 家中第 66 低 |
Statement figures are for the period to 30 Jun 2026, filed by 140 of 140 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，140 家同业中 140 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics 迈瑞医疗 | ¥1,918亿 | 24.4x | 4.7x | 6.0% | 28.4% | 12.0% | C |
| Shanghai United Imaging Healthcare 联影医疗 | ¥873亿 | 49.4x | 4.0x | 17.2% | 12.6% | 4.1% | D |
| Shenzhen New Industries Biomedical 新产业 | ¥390亿 | 22.7x | 4.3x | 10.8% | 35.9% | 9.3% | B |
| APT Medical 惠泰医疗 | ¥342亿 | 36.7x | 11.1x | 25.7% | 34.6% | 16.0% | B |
| Wantai Biological 万泰生物 | ¥337亿 | — | 2.9x | 24.3% | -12.6% | -1.1% | D |
| Intco Medical Technology 英科医疗 | ¥317亿 | 27.9x | 1.7x | 40.6% | 13.1% | 4.5% | C |
| MGI Tech 华大智造 | ¥303亿 | — | 4.3x | 18.9% | -11.6% | -2.2% | D |
| Andon Health 九安医疗 | ¥276亿 | 6.2x | 1.2x | -30.6% | 578.7% | 13.7% | C |
| IRAY Group 奕瑞科技 | ¥266亿 | 36.9x | 3.4x | 56.7% | 25.0% | 6.4% | C |
| Jiangsu Yuyue Medical Equipment & Supply 鱼跃医疗 | ¥262亿 | 23.3x | 2.0x | -1.9% | 18.6% | 6.2% | C |
| Weigao Blood Purification 威高血净 | ¥216亿 | 43.9x | 1.8x | -0.4% | 13.1% | 3.2% | D |
| Lepu Medical Technology 乐普医疗 | ¥210亿 | 27.3x | 1.3x | -4.6% | 14.2% | 3.0% | D |
| Zhende Medical 振德医疗 | ¥197亿 | 71.3x | 3.5x | 5.9% | 6.8% | 2.5% | D |
| Autobio 安图生物 | ¥195亿 | 19.6x | 2.2x | -0.1% | 24.4% | 5.5% | C |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。